Studies employing standardized toxicity tests have thus far supported the safety of current low levels of human exposure to BPA. However, on the basis of results from recent studies using novel approaches to test for subtle effects, both the National Toxicology Program at the National Institutes of Health and the FDA have some concern about the potential effects of BPA on the brain, behavior and prostate gland in fetuses, infants, and young children. In cooperation with the National Toxicology Program, the FDA’s National Center for Toxicological Research is carrying out in-depth studies to answer key questions and clarify uncertainties about the risks of BPA.
The FDA Backtracks on BPA Safety
Studies employing standardized toxicity tests have thus far supported the safety of current low levels of human exposure to BPA. However, on the basis of results from recent studies using novel approaches to test for subtle effects, both the National Toxicology Program at the National Institutes of Health and the FDA have some concern about the potential effects of BPA on the brain, behavior and prostate gland in fetuses, infants, and young children. In cooperation with the National Toxicology Program, the FDA’s National Center for Toxicological Research is carrying out in-depth studies to answer key questions and clarify uncertainties about the risks of BPA.